Immitra Bio raises $3M
Immitra Bio announced a Pre-Seed round of $3M on 21 July 2026. The company operates in HealthTech and is based in Switzerland. It was founded by Jan Nelis, CEO & Co-founder.
Founder
Jan Nelis
CEO & Co-founder, Immitra Bio
Outreach angles
- -Jan Nelis co-founded Immitra Bio as a spinout from ETH Zurich genome-editing researcher Jacob Corn's lab.
- -He is building scalable in-vivo gene-editing therapies from Zurich.
- -The CHF 2.4M pre-seed led by Backbone Ventures advances Immitra's off-the-shelf gene-editing platform.
Signals
Pre-SeedHealthcareDeep TechRegulated IndustryB2BHiring
Round details
Company: Immitra Bio
Domain: immitrabio.com
Amount: $3M
Stage: Pre-Seed
Industry: HealthTech
Country: Switzerland
Announced: 21 July 2026
Other HealthTech raises
Recently funded in Switzerland